Differentiating Arteriolosclerotic Ulcers of Martorell from Other Types of Leg Ulcers Based on Vascular Histomorphology.

Martorell histomorphology hyalinosis leg ulcer arteriolosclerosis

Journal

Acta dermato-venereologica
ISSN: 1651-2057
Titre abrégé: Acta Derm Venereol
Pays: Sweden
ID NLM: 0370310

Informations de publication

Date de publication:
04 May 2021
Historique:
pubmed: 16 4 2021
medline: 24 6 2021
entrez: 15 4 2021
Statut: epublish

Résumé

Clinical differential diagnosis of arteriolosclerotic ulcers of Martorell is challenging due to the lack of clearly affirmative instrument-based diagnostic criteria. The aim of this study was to develop vascular histomorphological diagnostic criteria differentiating Martorell ulcers from other types of leg ulcers. The histomorphology of patients diagnosed with arteriolosclerotic ulcers of Martorell (n = 67) was compared with that of patients with venous leg ulcers, necrotizing leukocytoclastic vasculitis, pyoderma gangrenosum, and non-ulcerative controls (n = 15 each). In a multivariable logistic regression model, the rates of arteriolar calcification (odds ratio (OR) 42.71, 95% confidence interval (CI) 7.43-443.96, p < 0.001) and subendothelial hyalinosis (OR 29.28, 95% CI 4.88-278.21, p <0.001) were significantly higher in arteriolosclerotic ulcers of Martorell. Arteriolar cellularity was significantly lower in Martorell ulcers than in controls (OR 0.003, 95 CI < 0.001-0.97, p = 0.05). However, the wall-to-lumen ratio was similar in all ulcers (OR 0.975, 95% CI 0.598-2.04, p =0.929). Based on the Youden index, a wall cellularity of < 0.24 cells/100 μm2 was determined as the optimum cut-off point (sensitivity 0.955, specificity 0.944). Thus, arteriolar calcification, subendothelial hyalinosis, and arteriolar cellularity revealed high discriminatory power for arteriolosclerotic ulcers of Martorell.

Identifiants

pubmed: 33856037
doi: 10.2340/00015555-3804
pmc: PMC9367051
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

adv00449

Références

Postgrad Med J. 1995 Dec;71(842):717-9
pubmed: 8552533
Adv Skin Wound Care. 2012 Dec;25(12):535
pubmed: 23151758
Dermatology. 2016;232(5):523-533
pubmed: 27622522
Proc Staff Meet Mayo Clin. 1946 Sep 4;21(18):337-46
pubmed: 20997482
Int Angiol. 1992 Apr-Jun;11(2):132-6
pubmed: 1402217
J Hum Hypertens. 2001 Apr;15(4):279-83
pubmed: 11319677
Nature. 1997 Mar 6;386(6620):78-81
pubmed: 9052783
Br J Dermatol. 2018 Feb;178(2):e125-e126
pubmed: 28832960
Arch Dermatol. 2010 Sep;146(9):961-8
pubmed: 20855694
Ophthalmic Physiol Opt. 2014 Sep;34(5):502-8
pubmed: 24697967
J Eur Acad Dermatol Venereol. 2006 Feb;20(2):166-9
pubmed: 16441624
J Am Soc Nephrol. 2017 Jun;28(6):1717-1722
pubmed: 28049648
Case Rep Dermatol. 2015 Aug 05;7(2):199-206
pubmed: 26351431
J Invest Dermatol. 1947 Dec;9(6):285-98
pubmed: 18918923
J Cardiovasc Surg (Torino). 1978 Nov-Dec;19(6):599-600
pubmed: 739031
Am J Pathol. 1986 Mar;122(3):410-20
pubmed: 2420184
Clin Exp Dermatol. 1995 Mar;20(2):107-14
pubmed: 8565243
Adv Skin Wound Care. 2012 Dec;25(12):563-72; quiz 573-4
pubmed: 23151767
Med Klin. 1957 Nov 8;52(45):1945-6
pubmed: 13492988
Eur J Case Rep Intern Med. 2018 Oct 24;5(10):000952
pubmed: 30755982
Br J Dermatol. 2003 Mar;148(3):388-401
pubmed: 12653729
Wounds. 2018 Feb;30(2):E9-E12
pubmed: 29481334
Ann Epidemiol. 2019 Jan;29:8-15
pubmed: 30497932
Am J Cardiol. 1966 Apr;17(4):560-5
pubmed: 5929662
Trends Mol Med. 2013 Apr;19(4):217-26
pubmed: 23375872
J Eur Acad Dermatol Venereol. 2010 Aug;24(8):867-74
pubmed: 20113382
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Am J Pathol. 2019 Dec;189(12):2503-2515
pubmed: 31539519
N Engl J Med. 2003 Mar 13;348(11):1064-6; author reply 1064-6
pubmed: 12637622
Dermatology. 2018;234(5-6):194-197
pubmed: 30199871
Case Rep Dermatol. 2017 Apr 7;9(1):95-102
pubmed: 28512404
Reg Anesth Pain Med. 2011 Jan-Feb;36(1):83-6
pubmed: 21455092

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH